NBC Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
NBC Securities's MRNA Position: Q3 2026 in Review
NBC Securities reduced its Moderna (MRNA) stake by 18% in Q3 2026, selling an estimated $5.39K and leaving 229 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.
NBC Securities first reported a position in MRNA in Q3 2023 and has held it in 12 quarters since. The position peaked at $122K in Q1 2024. 1,034 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- NBC Securities held 229 shares of Moderna worth $44.1K as of Q3 2026.
- NBC Securities sold 50 Moderna shares in Q3 2026, an estimated $5.39K.
- Moderna made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #1350 holding.
- NBC Securities first reported a position in Moderna in Q3 2023 and has held it in 12 quarters since.
- NBC Securities's Moderna position peaked at $122K in Q1 2024.
- 1,034 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.